Aurora, CONCT07201402Now EnrollingIRB Ready

Contraception Clinical Trial in Aurora, CO

Access cutting-edge contraception treatment through this clinical trial at a research site in Aurora. Study-provided care at no cost to qualified participants.

Sponsored by Yale University

Quick Self-Assessment

See if you qualify for this Aurora location

Preparing your pre-screening questions…

Expert Care in Aurora

Access contraception specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related contraception treatment provided free

Apply for This Aurora Location

Check if you qualify for this contraception clinical trial in Aurora, CO

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Aurora

    Convenient for CO residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Aurora site if eligible
  4. 4Begin participation

About This Contraception Study in Aurora

This study aims to evaluate long-term outcomes when the etonogestrel contraceptive implant is inserted at an alternative site located over the scapular. The study will evaluate the pharmacokinetics (i.e., drug levels) and side effect profiles of participants who have an etonogestrel contraceptive implant inserted at this alternative scapular site over the course of at least two years.

Sponsor: Yale University

Who Can Participate

Inclusion Criteria

Provision of signed and dated informed consent form
Stated willingness to comply with all study procedures and availability for the duration of the study
Sex assigned at birth must be Female
Aged 18-45 years
In good general health as evidenced by medical history and no need for regular intensive medical interventions (e.g., inpatient admissions, surgical treatments). The Principal Investigator will be responsible for determining good general health for potential participants with complicated medical histories
Interest and willingness to use an etonogestrel contraceptive implant
Negative pregnancy test at the time of study enrollment and not planning to become pregnant in the next 36 months
Willing to abstain from medications and supplements known to induce/inhibit CYP3A (e.g., rifampin, carbamazepine, ketoconazole, St. John's wort) during the study. In the inducer/inhibitor CYP3A medication is a prescribed medication, individuals must provide the prescriber information for the PI to confirm it is safe for this medication to be abstained during the study
Body-mass index ≥18.5kg/m2

Exclusion Criteria

Self-reported contraindications to the use of the ENG implant based on the CDC Medical Eligibility Criteria guidelines for any conditions with a category 3 or 4 recommendation
Current breast cancer or personal history of breast cancer
Malignant liver tumor (hepatocellular carcinoma)
Allergic reaction to any components of the ENG implant
Any self-reported known liver conditions that could affect drug metabolism (e.g., cirrhosis, hepatitis)
Personal history of deep vein thrombosis (DVT), venous thromboembolism (VTE), or arterial thromboembolism (ATE).
Currently taking and unable or unwilling to abstain from any medications or supplements known to be CYP3A inducers/inhibitors.
Current use of a progestin-only contraceptive method containing desogestrel or etonogestrel
History of spinal deformity (e.g., kyphosis, lordosis)
History of shoulder or scapular surgery on the non-dominant side
Non-dominant shoulder mobility limitations
Previous trauma to the non-dominant scapular region
Active skin conditions (e.g., psoriasis) in the non-dominant scapular region
Inability to palpate the bony landmarks of the scapula due to adiposity or other body habitus

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Aurora?

Yes, this clinical trial (NCT07201402) has an active research site in Aurora, CO that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Contraception Treatment Options in Aurora, CO

If you're searching for contraception treatment options in Aurora, CO, this clinical trial (NCT07201402) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Aurora research site is actively enrolling participants for this clinical trial. You'll receive care from experienced contraception specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all contraception clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Aurora, CO

See all rheumatoid arthritis clinical trials recruiting in Aurora — not just this study.

Browse Rheumatoid Arthritis Trials in Aurora

Browse More Trials by Condition

Ready to Join in Aurora?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Aurora, CO